Back to Bills
SENATE-BILL 4109119th Congress

SENATE-BILL 4109: S.4109 - Stem Cell Therapeutic and Research Reauthorization Act of 2026

Introduced: March 17, 2026
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

SENATE-BILL 4109 aims to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with a focus on expanding access to stem cell therapies, particularly those derived from cord blood. The legislation addresses major themes such as health care access, ethical considerations in stem cell research, and informed consent. Key provisions include increased funding for the C.W. Bill Young Cell Transplantation Program, extending its authorization until 2031, and implementing a structured regulatory framework for cord blood management. The bill's long-term commitment to stem cell research is expected to enhance treatment options for patients with conditions treatable by stem cell transplantation. However, it raises constitutional concerns regarding health care rights, reproductive autonomy, and the ethical sourcing of stem cells. The implementation timeline is set until 2031, indicating a sustained effort to improve research and treatment availability for individuals in need.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill has significant implications for individual rights, particularly in the realm of healthcare access and medical advancements. It aims to enhance the availability of stem cell therapies, which can improve health outcomes for various demographic groups.

Key Individual Rights

  • Right to Health Care
  • Equal Protection under the Law
  • Right to Privacy

Constitutional Provisions

  • 14th Amendment - Equal Protection Clause
  • Right to Privacy (implied from the 1st, 4th, and 9th Amendments)

Potential Constitutional Challenges

Challenges may arise if the implementation of the bill leads to unequal access to therapies based on demographic factors such as race, income, or disability status. Additionally, concerns regarding informed consent and the privacy of medical information could lead to legal scrutiny.

Summary

SENATE-BILL 4109 aims to reauthorize and fund stem cell research, which has the potential to significantly benefit individuals across various demographic categories, including infants, seniors, and those with disabilities. However, it is crucial that the bill's implementation ensures equitable access to these therapies to avoid violating the Equal Protection Clause. The bill supports advancements in medical research, aligning with constitutional principles of promoting public health while necessitating careful oversight to protect individual rights.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention S. 4109 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

March 17, 2026

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat